Related Experiment Video

Updated: Feb 13, 2026

Implantation of an Isoproterenol Mini-Pump to Induce Heart Failure in Mice
05:08

Implantation of an Isoproterenol Mini-Pump to Induce Heart Failure in Mice

Published on: October 3, 2019

11.9K

Implantable devices for heart failure monitoring and therapy

Maxwell Eyram Afari1, Wajih Syed2, Lana Tsao2

  • 1Division of Cardiovascular Medicine, Steward St. Elizabeth's Medical Center, 736 Cambridge Street, Brighton, MA, 02135, USA. maxieafari@yahoo.co.uk.

Heart Failure Reviews
|March 11, 2018
PubMed

Insights

Heart failure (HF) remains a major health challenge with high mortality. Innovative implantable devices offer new monitoring and treatment options for patients with advanced heart failure.

Area of Science:

  • Cardiology
  • Biomedical Engineering

Background:

  • Heart failure (HF) is a growing cardiovascular epidemic with significant morbidity, mortality, and increasing healthcare costs.
  • Despite advances in pharmacologic therapy, 5-year survival for HF remains suboptimal at 61%, highlighting unmet clinical needs.
  • Patients face challenges including lifestyle modifications, treatment adherence, financial constraints, and side effects, particularly those with advanced (ACC/AHA stage D) or non-transplant-candidate (ACC/AHA stage C) heart failure.

Purpose of the Study:

  • To review innovative implantable devices for monitoring and treating heart failure.
  • To explore emerging technologies addressing the limitations of current heart failure management.
  • To discuss devices under investigation or approved for add-on therapy in heart failure patients.

Main Methods:

  • This is a review article, synthesizing information from existing literature and clinical data.
  • The review focuses on implantable devices as add-on therapy for heart failure.
  • It covers devices in various stages of development and approval.

Main Results:

  • The review discusses various innovative implantable devices for heart failure management.
  • These devices aim to improve monitoring and treatment efficacy.
  • The focus is on add-on therapies for patients not candidates for advanced treatments like heart transplant or LVADs.

Conclusions:

  • Implantable devices represent a promising area for improving heart failure care.
  • These technologies address challenges in monitoring and treatment adherence.
  • Further development and integration of devices are crucial for managing the increasing burden of heart failure.

Keywords:
Heart failureImplantable devicesMonitoringTherapy

More Related Videos

Benefits of Cardiac Resynchronization Therapy in an Asynchronous Heart Failure Model Induced by Left Bundle Branch Ablation and Rapid Pacing12:45

Benefits of Cardiac Resynchronization Therapy in an Asynchronous Heart Failure Model Induced by Left Bundle Branch Ablation and Rapid Pacing

Published on: December 11, 2017

11.0K
Implantation of Total Artificial Heart in Congenital Heart Disease07:27

Implantation of Total Artificial Heart in Congenital Heart Disease

Published on: July 18, 2014

25.2K

Related Concept Videos

Heart Failure VI: Adjunct Therapies01:22

Heart Failure VI: Adjunct Therapies

Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
399
Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
1.0K
Pathophysiology of Heart Failure01:17

Pathophysiology of Heart Failure

Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
4.0K
Heart Failure I: Introduction01:27

Heart Failure I: Introduction

Heart failure refers to a clinical syndrome caused by structural or functional cardiac disorders that prevent the heart from pumping an adequate amount of blood to meet the body's metabolic needs. This condition often arises from myocardial infarction or ischemia, leading to decreased cardiac output, reduced tissue perfusion, impaired gas exchange, fluid volume imbalance, and decreased functional ability.Heart failure can result from disruptions in the mechanisms that regulate cardiac output...
958
Heart Failure Drugs: Diuretics01:22

Heart Failure Drugs: Diuretics

Heart failure and kidney perfusion are interconnected in a complex way. Reduced renal perfusion and venous congestion are two significant factors that contribute to renal dysfunction in heart failure. The kidneys, primarily responsible for fluid balance in the body, are adversely affected due to compromised cardiac output and increased venous pressure. In response to reduced renal perfusion, the kidneys activate neurohumoral mechanisms to restore balance. However, these mechanisms can be...
1.0K
Heart Failure V: Medical Management01:30

Heart Failure V: Medical Management

Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...
363